A randomized comparative study of methylcobalamin, methylcobalamin plus pregabalin and methylcobalamin plus duloxetine in patients of painful diabetic neuropathy

CONTEXT: Diabetic neuropathy affects 10.5%–32.2% of diabetic population posing clinical burden onto society. AIMS: We aimed to study the efficacy, safety, and tolerability of methylcobalamin, methylcobalamin plus pregabalin, and methylcobalamin plus duloxetine in patients of painful diabetic neuropa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Chetna, Kaur, Inderpal, Singh, Harpreet, Grover, Inderpal Singh, Singh, Jatinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641739/
https://www.ncbi.nlm.nih.gov/pubmed/34854403
http://dx.doi.org/10.4103/ijp.ijp_1159_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641739/
https://www.ncbi.nlm.nih.gov/pubmed/34854403
http://dx.doi.org/10.4103/ijp.ijp_1159_20

Ejemplares similares